MedPath

Effect Ashang and Persian Medicine dietary modification with Mefenamic acid on menorrhagia

Phase 3
Recruiting
Conditions
Excessive and frequent menstruation with regular cycle.
Excessive and frequent menstruation with regular cycle
N92.0
Registration Number
IRCT20221212056789N1
Lead Sponsor
Gorgan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
120
Inclusion Criteria

Unmarried women, 18-50 years old
Regular menstrual cycle
Suffering from menorrhagia based on PBAC criteria
Patient satisfaction
Hemoglobin more than 10

Exclusion Criteria

Severe uterine bleeding that requires surgical interventions
Pregnancy or breastfeeding

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Primary outcome: Higham questionnaire score (PBAC)(Pictorial Blood loss Assessment Chart). Timepoint: At the beginning of the study (before the start of the intervention) and at the end of the study period, i.e. after 3 cycles of treatment with Ashang. Method of measurement: Higham Questionnaire (PBAC).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath